Psychiatry
3 drugs are in development for Schizophrenia.
- Companies
- 3
- Clinical trials
- 94
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Schizophrenia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| NUPLAZID | ACADIA PHARMACEUTICALS INC (ACAD) |
Phase 2(2)
About this indication
Schizophrenia context
Psychiatry·MeSH: Schizophrenia (D012559)
Also known as: Dementia Praecox, Disorder, Schizophrenic, Disorders, Schizophrenic, Schizophrenias
Prevalence
300.0 / 100K
Incidence
15.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Schizophrenia?
BioSniper tracks 3 drugs in development for Schizophrenia across 3 companies.
How many clinical trials target Schizophrenia?
There are 94 clinical trials targeting Schizophrenia tracked by BioSniper.
What is the prevalence of Schizophrenia?
The estimated prevalence of Schizophrenia is approximately 300.0 per 100,000 population.